BioPharm.Si (Q3270309): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: modifying budgets in slovenia one item from slovenia)
Property / intervention field
 
Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank
 
Normal rank
Property / intervention field
 
Property / intervention field: Cluster support and business networks primarily benefiting SMEs / rank
 
Normal rank
Property / intervention field
 
Property / intervention field: Research and innovation activities in public research centres and centres of competence including networking / rank
 
Normal rank
Property / intervention field
 
Property / intervention field: Research and innovation processes in SMEs (including voucher schemes, process, design, service and social innovation) / rank
 
Normal rank
Property / EU contribution
 
4,777,897.3 Euro
Amount4,777,897.3 Euro
UnitEuro
Property / EU contribution: 4,777,897.3 Euro / rank
 
Normal rank
Property / co-financing rate
 
80.0 percent
Amount80.0 percent
Unitpercent
Property / co-financing rate: 80.0 percent / rank
 
Normal rank

Revision as of 14:14, 20 October 2021

Project Q3270309 in Slovakia
Language Label Description Also known as
English
BioPharm.Si
Project Q3270309 in Slovakia

    Statements

    0 references
    4,777,897.3 Euro
    0 references
    5,972,371.63 Euro
    0 references
    80.0 percent
    0 references
    7 July 2016
    0 references
    31 December 2021
    0 references
    CO BIK
    0 references
    0 references

    45°53'28.61"N, 13°53'57.23"E
    0 references
    5270
    0 references
    Nova Generacija bioloških zdravil (Slovenian)
    0 references
    New Generation of Biological Drugs (English)
    12 October 2021
    0 references

    Identifiers

    OP20.00363
    0 references